Raphael Giami

Serving as CEO at Panacea-ml, Raphaël has an extensive experience in the drug development business sector relying on diverse expertise to transform clinical trials and processes optimization based on disruptive technologies, SaaS products and innovative business models compatible with the industry's culture. Prior to joining Panacea-ml, Raphaël started his career in the Pharma industry at Roche and GSK, moved to the CRO sector during which he founded a technological service company, and served as the Director of innovation at the Novolog Healthcare Group. He holds a LL.M in Healthcare products and Pharmaceutical Law (La Sorbonne & Paris V) and an MBA of Healthcare Innovation and Entrepreneurship (Reichmann U.).